Point-of-care testing (POCT) continues to transform diagnostic practice across the UK, playing an ever-greater role in speeding up clinical decision-making, enhancing patient flow, and supporting more efficient use of healthcare resources. As health systems face increasing pressures – from higher patient volumes to workforce constraints – POCT provides a practical solution by enabling rapid testing at or near the site of care. This reduces dependence on central laboratory turnaround times, particularly in time-critical pathways such as emergency medicine, cardiology, and infectious disease management.
Against this backdrop, clinical services require POCT solutions that are not only fast and reliable but also aligned with NHS governance, training, and quality assurance frameworks. Recognising these needs, Sussex Biologicals Limited is pleased to introduce the FIAPro™ Immunofluorescence Analyser to its diagnostic portfolio. The FIAPro™ is a compact, high-performance platform capable of delivering quantitative and qualitative immunofluorescence results across a broad range of sample types and clinical indications.
Designed Specifically for POCT Environments
The FIAPro™ Immunofluorescence Analyser has been engineered with the realities of point-of-care operation in mind. It employs advanced LED-based excitation technology paired with a high-sensitivity photodetector, enabling precise and reproducible fluorescence measurement. This ensures laboratory-quality performance even outside traditional laboratory settings.
The analyser supports multiple specimen types including whole blood, serum, plasma, urine, and faeces – making it highly versatile for both acute and outpatient environments. Depending on the assay selected, results are generated within 3 to 15 minutes, enabling clinicians to make timely decisions at the bedside or within community care settings.
Common POCT deployment areas include:
- Emergency departments and rapid triage units
- Acute medical units and same-day emergency care
- Outpatient clinics and specialist ambulatory services
- Community pathways, including GP surgeries and urgent treatment centres
- Decentralised or outreach models supporting remote care delivery
Importantly, the analyser and its associated consumables comply with UK POCT governance requirements. This includes compatibility with hospital quality frameworks, traceability standards, operator competency structures, and external quality assessment (EQA) expectations. As a result, the FIAPro™ supports both clinical reliability and seamless integration into existing governance processes.
A Single Platform Supporting Multiple Clinical Pathways
Many hospitals face challenges when managing multiple POCT platforms across departments – each with its own training requirements, quality protocols, procurement channels, and maintenance needs. The FIAPro™ system addresses this by consolidating numerous assays onto a single, user-friendly platform, simplifying both clinical and operational oversight.
The broad and expanding test menu includes, but is not limited to:
Cardiac Markers
- hs-cTnI for high-sensitivity detection of myocardial injury
- NT-proBNP supporting heart failure diagnosis and monitoring
- D-dimer for exclusion of thromboembolic conditions
Infectious Diseases
- Flu A/B and RSV for respiratory virus triage
- H. pylori antigen for gastrointestinal diagnostic support
- Malaria (P.f./Pan, P.f./P.v.) for rapid detection in travel medicine and emergency care
Inflammation & Sepsis
- Procalcitonin (PCT) for antibiotic stewardship and sepsis pathway
- CRP and hsCRP supporting differentiation of bacterial vs viral infection
Endocrinology
- TSH, FT3, FT4 for rapid thyroid function screening
- AMH supporting fertility assessments
- Cortisol for adrenal health evaluation
Diabetes & Renal Monitoring
- HbA1c for diabetic diagnosis and monitoring at the point of care
- Microalbumin and Cystatin C for early renal impairment detection
Nutrition & Anaemia
- Vitamin D, Folic Acid, and Ferritin assays
Oncology Screening
- FOB for bowel screening
- CA125 for ovarian cancer monitoring
This extensive assay menu aids platform consolidation, simplifies operator training, reduces governance complexity, and enables greater consistency in POCT service delivery across departments.
The reagents are stable at room temperature each assay kit comes with the required controls that meet UK POCT guidelines.
Operational Benefits for Hospital and Community Services
Beyond delivering analytical accuracy, a modern POCT system must provide operational value. The FIAPro™ Immunofluorescence Analyser supports multiple efficiencies, including:
- Faster rule-in and rule-out decisions, particularly in chest pain, heart failure, respiratory infection, and sepsis pathways
- Improved patient flow, reducing bottlenecks in emergency and acute care settings
- Reduced reliance on central laboratory turnaround times, essential during peak operational pressure
- Support for community-based and decentralised models, enabling diagnostics closer to home
- Standardisation of POCT across clinical areas, reducing variation and improving auditability
The analyser’s compact footprint allows installation in space-constrained clinical environments, while its intuitive interface enables rapid operator onboarding and minimises training burden.
About Sussex Biologicals Limited
Founded in 2014 and headquartered in Lower Dicker, East Sussex, Sussex Biologicals Limited is a UK-based, privately owned organisation specialising in high-quality diagnostic solutions. Its portfolio spans:
- Diagnostic reagents and consumables
- Point-of-care testing systems
- DNA-based technologies including PCR and next-generation sequencing
- Laboratory Information Management Systems (LIMS)
The company’s mission is to supply reliable, compliant, and clinically relevant diagnostics that support the evolving needs of modern healthcare – across hospitals, community settings, specialist clinics, and research environments.
Further Information
For enquiries regarding the FIAPro™ Immunofluorescence Analyser, including assay availability, technical specifications, governance documentation, or discussions with POCT and pathology teams:
info@sussexbiologicals.co.uk
www.sussexbiologicals.co.uk